UK markets open in 7 hours 29 minutes

Hofseth BioCare ASA (0Q6H.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
2.1564-0.8536 (-28.36%)
At close: 12:47PM BST
Currency in NOK

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.44
52-week change 3-10.15%
S&P500 52-week change 323.06%
52-week high 33.3500
52-week low 30.0000
50-day moving average 33.2200
200-day moving average 33.2200

Share statistics

Avg vol (3-month) 335.39k
Avg vol (10-day) 335.39k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8179.81M
% held by insiders 158.22%
% held by institutions 140.60%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -48.82%
Operating margin (ttm)-103.91%

Management effectiveness

Return on assets (ttm)-16.00%
Return on equity (ttm)-112.79%

Income statement

Revenue (ttm)218.51M
Revenue per share (ttm)0.55
Quarterly revenue growth (yoy)41.10%
Gross profit (ttm)N/A
EBITDA -89.83M
Net income avi to common (ttm)-106.68M
Diluted EPS (ttm)-0.3780
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)23.89M
Total cash per share (mrq)0.06
Total debt (mrq)280.79M
Total debt/equity (mrq)682.52%
Current ratio (mrq)0.52
Book value per share (mrq)0.11

Cash flow statement

Operating cash flow (ttm)2.76M
Levered free cash flow (ttm)-100.88M